

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The role of pulmonary arterial... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-2124/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-2124" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis" />
    
            <meta name="og:title" content="F1000Research Article: The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.">
            <meta name="og:description" content="Read the latest article version by Michael H Lee, Todd M Bull, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="22318">
            <meta name="article-id" content="20313">
            <meta name="dc.title" content="The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis">
            <meta name="dc.description" content="Pulmonary arterial hypertension, categorized as group 1 pulmonary hypertension by the World Health Organization classification system, represents a major complication of systemic sclerosis resulting from pulmonary vascular involvement of the disease. The high mortality seen in systemic sclerosis-associated pulmonary arterial hypertension is likely due to the impairment of right ventricular systolic function and the coexistence of other non-group-1 pulmonary hypertension phenotypes that may negatively impact clinical response to pulmonary arterial hypertension-targeted therapy. This review highlights two areas of recent advances regarding the management of systemic sclerosis patients with pulmonary hypertension: the tolerability of pulmonary arterial hypertension-targeted therapy in the presence of mild to moderate interstitial lung disease and the potential clinical significance of the antifibrotic effect of soluble guanylate cyclase stimulators demonstrated in preclinical studies.">
            <meta name="dc.subject" content="Pulmonary arterial hypertension, pulmonary hypertension, systemic sclerosis">
            <meta name="dc.creator" content="Lee, Michael H">
            <meta name="dc.creator" content="Bull, Todd M">
            <meta name="dc.date" content="2019/12/19">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.20313.1">
            <meta name="dc.source" content="F1000Research 2019 8:2124">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Pulmonary arterial hypertension">
            <meta name="prism.keyword" content="pulmonary hypertension">
            <meta name="prism.keyword" content="systemic sclerosis">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/12/19">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="2124">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.20313.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-2124">
            <meta name="citation_title" content="The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis">
            <meta name="citation_abstract" content="Pulmonary arterial hypertension, categorized as group 1 pulmonary hypertension by the World Health Organization classification system, represents a major complication of systemic sclerosis resulting from pulmonary vascular involvement of the disease. The high mortality seen in systemic sclerosis-associated pulmonary arterial hypertension is likely due to the impairment of right ventricular systolic function and the coexistence of other non-group-1 pulmonary hypertension phenotypes that may negatively impact clinical response to pulmonary arterial hypertension-targeted therapy. This review highlights two areas of recent advances regarding the management of systemic sclerosis patients with pulmonary hypertension: the tolerability of pulmonary arterial hypertension-targeted therapy in the presence of mild to moderate interstitial lung disease and the potential clinical significance of the antifibrotic effect of soluble guanylate cyclase stimulators demonstrated in preclinical studies.">
            <meta name="citation_description" content="Pulmonary arterial hypertension, categorized as group 1 pulmonary hypertension by the World Health Organization classification system, represents a major complication of systemic sclerosis resulting from pulmonary vascular involvement of the disease. The high mortality seen in systemic sclerosis-associated pulmonary arterial hypertension is likely due to the impairment of right ventricular systolic function and the coexistence of other non-group-1 pulmonary hypertension phenotypes that may negatively impact clinical response to pulmonary arterial hypertension-targeted therapy. This review highlights two areas of recent advances regarding the management of systemic sclerosis patients with pulmonary hypertension: the tolerability of pulmonary arterial hypertension-targeted therapy in the presence of mild to moderate interstitial lung disease and the potential clinical significance of the antifibrotic effect of soluble guanylate cyclase stimulators demonstrated in preclinical studies.">
            <meta name="citation_keywords" content="Pulmonary arterial hypertension, pulmonary hypertension, systemic sclerosis">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Michael H Lee">
            <meta name="citation_author_institution" content="Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Colorado, USA">
            <meta name="citation_author" content="Todd M Bull">
            <meta name="citation_author_institution" content="Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Colorado, USA">
            <meta name="citation_publication_date" content="2019/12/19">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="2124">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.20313.1">
            <meta name="citation_firstpage" content="2124">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-2124/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-2124.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=22318 /> <input type=hidden id=articleId name=articleId value=20313 /> <input type=hidden id=xmlUrl value="/articles/8-2124/v1/xml"/> <input type=hidden id=xmlFileName value="-8-2124-v1.xml"> <input type=hidden id=article_uuid value=dcfcf812-2363-4880-b2b8-f96a9d0090f3 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.20313.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.20313.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-2124"
  },
  "headline": "The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis",
  "datePublished": "2019-12-19T15:02:39",
  "dateModified": "2019-12-19T15:02:39",
  "author": [
    {
      "@type": "Person",
      "name": "Michael H Lee"
    },    {
      "@type": "Person",
      "name": "Todd M Bull"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Pulmonary arterial hypertension, categorized as group 1 pulmonary hypertension by the World Health Organization classification system, represents a major complication of systemic sclerosis resulting from pulmonary vascular involvement of the disease. The high mortality seen in systemic sclerosis-associated pulmonary arterial hypertension is likely due to the impairment of right ventricular systolic function and the coexistence of other non-group-1 pulmonary hypertension phenotypes that may negatively impact clinical response to pulmonary arterial hypertension-targeted therapy. This review highlights two areas of recent advances regarding the management of systemic sclerosis patients with pulmonary hypertension: the tolerability of pulmonary arterial hypertension-targeted therapy in the presence of mild to moderate interstitial lung disease and the potential clinical significance of the antifibrotic effect of soluble guanylate cyclase stimulators demonstrated in preclinical studies."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-2124.html",
            "name": "The role of pulmonary arterial hypertension-targeted therapy in systemic..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The role of pulmonary arterial hypertension-targeted therapy in systemic... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=22318 data-id=20313 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20313.1" data-recommended="" data-doi="10.12688/f1000research.20313.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-2124/v1/pdf?article_uuid=dcfcf812-2363-4880-b2b8-f96a9d0090f3" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-20313-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-20313-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-20313-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Lee MH and Bull TM. The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):2124 (<a class=new-orange href="https://doi.org/10.12688/f1000research.20313.1" target=_blank>https://doi.org/10.12688/f1000research.20313.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-20313-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=20313 id=track-article-signin-20313 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20313?target=/articles/8-2124.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22318 /> <input name=articleId type=hidden value=20313 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Michael H Lee<a href="https://orcid.org/0000-0002-5739-8369" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5739-8369</div>,&nbsp;</span><span class=""><a href="mailto:todd.bull@cuanschutz.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Todd M Bull</span></a></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Michael H Lee<a href="http://orcid.org/0000-0002-5739-8369" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5739-8369</div>,&nbsp;</span><span class=""><a href="mailto:todd.bull@cuanschutz.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Todd M Bull</span></a></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 19 Dec 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.20313.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Colorado, USA<br/> <p> <div class=margin-bottom> Michael H Lee <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Todd M Bull <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=61408-57680></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=61403-57679></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Pulmonary arterial hypertension, categorized as group 1 pulmonary hypertension by the World Health Organization classification system, represents a major complication of systemic sclerosis resulting from pulmonary vascular involvement of the disease. The high mortality seen in systemic sclerosis-associated pulmonary arterial hypertension is likely due to the impairment of right ventricular systolic function and the coexistence of other non-group-1 pulmonary hypertension phenotypes that may negatively impact clinical response to pulmonary arterial hypertension-targeted therapy. This review highlights two areas of recent advances regarding the management of systemic sclerosis patients with pulmonary hypertension: the tolerability of pulmonary arterial hypertension-targeted therapy in the presence of mild to moderate interstitial lung disease and the potential clinical significance of the antifibrotic effect of soluble guanylate cyclase stimulators demonstrated in preclinical studies. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Pulmonary arterial hypertension, pulmonary hypertension, systemic sclerosis </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Todd M Bull (<a href="mailto:todd.bull@cuanschutz.edu">todd.bull@cuanschutz.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Todd M Bull </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> TMB has received grant support from and has served as a consultant for Bayer Pharmaceuticals. MHL declares that he has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Lee MH and Bull TM. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Lee MH and Bull TM. The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):2124 (<a href="https://doi.org/10.12688/f1000research.20313.1" target=_blank>https://doi.org/10.12688/f1000research.20313.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 19 Dec 2019, <b>8</b>(F1000 Faculty Rev):2124 (<a href="https://doi.org/10.12688/f1000research.20313.1" target=_blank>https://doi.org/10.12688/f1000research.20313.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 19 Dec 2019, <b>8</b>(F1000 Faculty Rev):2124 (<a href="https://doi.org/10.12688/f1000research.20313.1" target=_blank>https://doi.org/10.12688/f1000research.20313.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d27117e142>Introduction</h2><p class="" id=d27117e145>Systemic sclerosis (SSc) is a systemic rheumatic disease characterized by autoimmunity, vascular injury, and unchecked collagen synthesis leading to fibrosis of the skin and internal organs<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. Based on the extent of skin fibrosis, SSc has been classified as either limited cutaneous or diffuse cutaneous phenotype<sup><a href="#ref-3">3</a></sup>, with diffuse cutaneous SSc characterized by earlier and more frequent internal organ involvement<sup><a href="#ref-4">4</a></sup>. The term “systemic sclerosis sine scleroderma” is sometimes used to refer to SSc with visceral organ involvement in the absence of cutaneous manifestation<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>.</p><p class="" id=d27117e170>One major complication of SSc is pulmonary arterial hypertension (PAH). Historically, PAH has been quoted as one of the leading causes of death in patients with SSc<sup><a href="#ref-7">7</a>–<a href="#ref-11">11</a></sup>. PAH represents group 1 pulmonary hypertension (PH) in the World Health Organization (WHO) classification system, characterized by elevated mean pulmonary arterial pressure (mPAP) ≥25 mmHg with elevated pulmonary vascular resistance (PVR) ≥3 Wood units and normal pulmonary capillary wedge pressure (PCWP) ≤15 mmHg in the absence of etiologies known to cause other groups (2–5) of PH<sup><a href="#ref-12">12</a></sup>. More recently, mPAP &gt;20 mmHg has been proposed as a new definition of precapillary PH, which includes PAH<sup><a href="#ref-13">13</a></sup>. Approximately 10% of SSc patients (under the original definition) are affected by PAH<sup><a href="#ref-10">10</a>,<a href="#ref-14">14</a>–<a href="#ref-16">16</a></sup>, and a similar prevalence was re-demonstrated in a recent study<sup><a href="#ref-17">17</a></sup>. While SSc-associated PAH (SSc-PAH) comprises a major proportion of PAH registries<sup><a href="#ref-18">18</a></sup>, less is known about its incidence, with one study reporting 0.61 cases per 100 patient-years<sup><a href="#ref-19">19</a></sup>.</p><p class="" id=d27117e211>SSc-PAH, which can complicate both limited and diffuse cutaneous subtypes of SSc<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>, suffers from a particularly poor prognosis. The presence of PAH predicts early death in SSc<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>, and mortality associated with SSc-PAH is higher than that seen in other PH groups and even other subtypes of PAH<sup><a href="#ref-23">23</a></sup>. Multiple studies demonstrated poorer survival in SSc-PAH compared to idiopathic PAH (IPAH) despite less pronounced hemodynamic derangement<sup><a href="#ref-23">23</a>–<a href="#ref-29">29</a></sup>. A recent retrospective study of 375 patients showed similar findings (median survival of 3 years in SSc-PAH versus 7.8 years in IPAH), and the difference in mortality was attributed to older age and more pronounced gas exchange impairment in SSc-PAH<sup><a href="#ref-30">30</a></sup>. Another plausible explanation for the high mortality in SSc-PAH is reduced contractility of the right ventricle (RV). A number of retrospective studies have consistently documented more impaired RV systolic function in SSc-PAH compared to that in IPAH for a given RV afterload<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>, and the RV function appears to improve with PAH-targeted therapy in IPAH but not in SSc-PAH<sup><a href="#ref-33">33</a></sup>. SSc-PAH is associated with worse outcomes and higher mortality, even when compared to other connective tissue disease-related PAH (CTD-PAH), suggesting that SSc-PAH represents a unique phenotype that perhaps should be managed differently to other subgroups of CTD-PAH<sup><a href="#ref-10">10</a>,<a href="#ref-25">25</a>,<a href="#ref-34">34</a></sup>.</p><p class="" id=d27117e265>The Ambrisentan and Tadalafil in Patients with Pulmonary Arterial Hypertension (AMBITION) trial was a recently published randomized double-blind multicenter study that compared upfront ambrisentan and tadalafil combination therapy to monotherapy in 500 treatment-naïve participants with WHO functional class II–III PAH<sup><a href="#ref-35">35</a></sup>. Clinical failure (defined as death, hospitalization for PAH, progression of disease, or unsatisfactory clinical response) was observed in 18% of those receiving the combination treatment compared to 31% of monotherapy recipients (hazard ratio of 0.50). After 24 weeks of intervention, the combination therapy was associated with improvements in secondary outcomes, including the 6-minute walk distance and N-terminal pro-brain natriuretic peptide levels, compared to pooled monotherapy. Other recent studies suggest that PAH-targeted therapy, such as the ambrisentan and tadalafil combination treatment, riociguat, and selexipag, likely confers clinical benefit in the subgroup of CTD-PAH patients<sup><a href="#ref-36">36</a>–<a href="#ref-38">38</a></sup>. The optimal medical therapy for the subset of SSc-PAH patients, however, is less defined<sup><a href="#ref-39">39</a></sup>, as demonstrated by the SSc-PAH-associated mortality that remains high<sup><a href="#ref-22">22</a>,<a href="#ref-40">40</a></sup> and largely unchanged over time<sup><a href="#ref-29">29</a>,<a href="#ref-34">34</a>,<a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. For instance, a recent study from the REVEAL registry (the Registry to Evaluate Early and Long-term PAH Disease Management) demonstrated that 5-year mortality in subjects newly diagnosed with SSc-PAH can be as high as 60%<sup><a href="#ref-41">41</a></sup>. Despite improved understanding of predictors of mortality in SSc-PAH<sup><a href="#ref-34">34</a>,<a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup> and the development of new prognostic models specifically validated in SSc-PAH cohorts<sup><a href="#ref-45">45</a>–<a href="#ref-47">47</a></sup>, clinical outcomes of SSc-PAH remain rather disappointing<sup><a href="#ref-48">48</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d27117e332>Innate heterogeneity of pulmonary hypertension in systemic sclerosis</h2><p class="" id=d27117e335>The poor clinical outcome and suboptimal response to treatment observed in SSc-PAH likely reflect the various phenotypes of PH that can coexist in SSc, precluding straightforward identification of those SSc patients with isolated PAH (<a href="#T1">Table 1</a>)<sup><a href="#ref-49">49</a></sup>. SSc is often complicated by fibrotic interstitial lung disease (ILD)<sup><a href="#ref-50">50</a>–<a href="#ref-52">52</a></sup>, more commonly in diffuse cutaneous SSc than in limited cutaneous SSc<sup><a href="#ref-53">53</a></sup>. The fibrotic ILD can be further complicated by neuromuscular weakness and chronic aspiration<sup><a href="#ref-54">54</a></sup>, contributing to the development of hypoxemia-induced (WHO group 3) PH. Unselected use of PAH-specific therapy with vasodilatory effect in the presence of ILD can exacerbate ventilation–perfusion (V/Q) mismatch, resulting in aggravation of hypoxemia and secondary PH<sup><a href="#ref-55">55</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Mechanisms of pulmonary hypertension in systemic sclerosis.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d27117e376 class=n-a></a><thead><a name=d27117e378 class=n-a></a><tr><a name=d27117e380 class=n-a></a><th align=left colspan=1 rowspan=1 valign=middle><a name=d27117e382 class=n-a></a>World Health<br class=br>Organization group</th><th align=left colspan=1 rowspan=1 valign=middle><a name=d27117e387 class=n-a></a>Mechanism of pulmonary hypertension</th></tr></thead><tbody><a name=d27117e392 class=n-a></a><tr><a name=d27117e394 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d27117e395 class=n-a></a>1</td><td align=left colspan=1 rowspan=1 valign=middle><a name=d27117e398 class=n-a></a>&nbsp;&nbsp;•&nbsp;&nbsp;Connective tissue disease-associated pulmonary arterial hypertension<br class=br>&nbsp;&nbsp;•&nbsp;&nbsp;Portopulmonary hypertension</td></tr><tr><a name=d27117e403 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d27117e404 class=n-a></a>1′</td><td align=left colspan=1 rowspan=1 valign=middle><a name=d27117e407 class=n-a></a>&nbsp;&nbsp;•&nbsp;&nbsp;Pulmonary veno-occlusive disease<br class=br>&nbsp;&nbsp;•&nbsp;&nbsp;Pulmonary capillary hemangiomatosis</td></tr><tr><a name=d27117e412 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d27117e413 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=middle><a name=d27117e416 class=n-a></a>&nbsp;&nbsp;•&nbsp;&nbsp;Myocardial fibrosis<br class=br>&nbsp;&nbsp;•&nbsp;&nbsp;Accelerated atherosclerosis<br class=br>&nbsp;&nbsp;•&nbsp;&nbsp;Kidney failure</td></tr><tr><a name=d27117e423 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d27117e424 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=middle><a name=d27117e427 class=n-a></a>&nbsp;&nbsp;•&nbsp;&nbsp;Interstitial lung disease (combined pulmonary fibrosis and emphysema)</td></tr><tr><a name=d27117e430 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d27117e431 class=n-a></a>4</td><td align=left colspan=1 rowspan=1 valign=middle><a name=d27117e434 class=n-a></a>&nbsp;&nbsp;•&nbsp;&nbsp;Venous thromboembolism/chronic thromboembolic pulmonary hypertension<br class=br>(antiphospholipid antibodies)</td></tr></tbody></table></div><p class="" id=d27117e442>One form of ILD increasingly recognized in SSc is combined pulmonary fibrosis and emphysema (CPFE)<sup><a href="#ref-56">56</a>–<a href="#ref-58">58</a></sup>. Although smoking history places SSc patients at a higher risk of developing CPFE<sup><a href="#ref-59">59</a></sup>, it is also observed in never-smokers and those with minimal tobacco history<sup><a href="#ref-57">57</a></sup>. A significant portion of SSc patients with CPFE go on to develop PH<sup><a href="#ref-60">60</a></sup>, illustrated by a recent study demonstrating a higher incidence of precapillary PH and higher mortality in 36 SSc-CPFE patients compared to 72 SSc-ILD patients without emphysema<sup><a href="#ref-59">59</a></sup>. Emphysema in CPFE can cause an additional reduction in carbon monoxide diffusing capacity (DLCO) and lung volume pseudo-normalization, and these physiologic consequences of CPFE can potentially compromise the diagnostic accuracy of PH in SSc patients with fibrotic ILD<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d27117e473>Under-recognized pulmonary venous hypertension in SSc is also believed to underlie the poor response to treatment and high mortality seen in SSc-PAH. Pathologic studies of lung tissues from SSc-PAH patients demonstrate fibrosis of veins and venules resulting in pulmonary veno-occlusive disease (PVOD)-like changes (WHO group 1)<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>. In patients with SSc-PAH, the presence of computed tomography findings suggestive of PVOD has been associated with pulmonary edema in response to vasodilator therapy and worse clinical outcomes<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>. Even more rarely, patients with SSc can suffer from pulmonary capillary hemangiomatosis (PCH), a disease that is now thought to be related to PVOD in its etiology<sup><a href="#ref-65">65</a></sup>. Other unrelated mechanisms by which SSc causes post-capillary PH and precipitates pulmonary edema include myocardial fibrosis<sup><a href="#ref-66">66</a>–<a href="#ref-68">68</a></sup> and ischemic heart disease due to accelerated atherosclerosis (WHO group 2)<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>. Subtle left ventricular diastolic dysfunction due to occult fibrosis of the myocardium may not be apparent and become unmasked with fluid challenge during cardiac catheterization<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d27117e514>Many studies have also documented the increased risk of venous thromboembolism (VTE) in SSc, which predisposes the patient to developing chronic thromboembolic PH (CTEPH, WHO group 4)<sup><a href="#ref-72">72</a>–<a href="#ref-74">74</a></sup>. There is an increased prevalence of antiphospholipid antibodies in SSc, although it remains unclear whether these antibodies represent the autoimmune nature of SSc-PAH, under-recognition of CTEPH, or both<sup><a href="#ref-75">75</a>–<a href="#ref-78">78</a></sup>. SSc is also associated with primary biliary cholangitis, which may subsequently produce portopulmonary hypertension<sup><a href="#ref-79">79</a>,<a href="#ref-80">80</a></sup>. These various phenotypes of PH often coexist in SSc, and they underscore the difficulty in selecting the right patient population who will benefit from PAH-targeted therapy or even anticoagulation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d27117e541>Pulmonary arterial hypertension-targeted therapy in systemic sclerosis patients with concurrent interstitial lung disease and precapillary pulmonary hypertension</h2><p class="" id=d27117e544>The role of PAH-targeted therapy in SSc patients with both ILD and precapillary PH represents a major area of uncertainty and interest to both clinicians and researchers. SSc often involves ILD<sup><a href="#ref-50">50</a>–<a href="#ref-53">53</a></sup>, and the presence of concurrent ILD is associated with increased mortality in SSc patients with precapillary PH<sup><a href="#ref-10">10</a>,<a href="#ref-42">42</a>,<a href="#ref-81">81</a>–<a href="#ref-83">83</a></sup>. While PAH-specific drugs may alleviate the increased PVR resulting from pulmonary arteriopathy of SSc, the often-coexisting ILD in this patient population has raised the concern of exacerbating V/Q mismatch as more blood flows to the non-ventilated parts of the lungs<sup><a href="#ref-55">55</a></sup>. As a result, there has been uncertainty regarding the tolerability of PAH-targeted therapy in SSc-associated precapillary PH owing to the high prevalence of concurrent ILD. Contrary to this historical perspective, however, two recent studies illustrate that PAH-targeted therapy may be well tolerated in the presence of ILD.</p><p class="" id=d27117e571>As previously mentioned, the AMBITION trial was a randomized double-blind study that demonstrated that the upfront combination therapy with ambrisentan and tadalafil protected treatment-naïve PAH patients from clinical worsening compared to monotherapy<sup><a href="#ref-35">35</a></sup>. A recent <i>post hoc</i> analysis of the AMBITION trial showed that the combination PAH-targeted therapy conferred similar clinical benefit in the subgroup of SSc-PAH patients<sup><a href="#ref-36">36</a></sup>. Of the 118 subjects with SSc-PAH, clinical failure (defined as death, hospitalization for PAH, progression of disease, or unsatisfactory clinical response) was seen in 21% of those receiving the combination treatment compared to 40% of monotherapy recipients (hazard ratio of 0.44 with 56% risk reduction). In the SSc-PAH subgroup, the combination therapy led to significantly improved outcomes compared to what had been previously reported in the general SSc-PAH patient population. While the AMBITION trial specifically targeted subjects with PAH, it is notable that the participants were allowed to have mild to moderate lung disease (total lung capacity [TLC] ≥60% of predicted normal, forced expiratory volume in 1 second [FEV1] ≥55% of predicted normal)<sup><a href="#ref-35">35</a></sup>. Therefore, it is probable that a substantial portion of the SSc-PAH subgroup had some degree of ILD or even SSc-ILD-PH, although the presence of severe ILD would have been unlikely given that the average TLC was 90% of predicted<sup><a href="#ref-36">36</a></sup>. The subgroup analysis did not investigate the effect of the combination therapy on hypoxemia and gas exchange; however, the study suggests PAH-targeted therapy with vasodilatory effect can be well tolerated in SSc-PAH patients with concurrent non-severe ILD, and it may be unnecessary to exclude a modest degree of ILD prior to trialing PAH-targeted therapy.</p><p class="" id=d27117e593>A more recent single-center cohort study evaluated response to PAH-targeted therapy in 29 SSc patients who had both right heart catheterization-proven PH and ILD visualized on high-resolution computed tomography of the chest<sup><a href="#ref-84">84</a></sup>. The ILDs in these patients were physiologically mild (forced vital capacity [FVC] 70.3% predicted, TLC 84.7% predicted, DLCO 43.1% predicted), followed either nonspecific interstitial pneumonia (NSIP) or usual interstitial pneumonia (UIP) pattern, and affected &gt;20% of the lungs in 65.5% (19 of 29) of cases. The majority of the participants had mild (mPAP 25–35 mmHg) or moderate (mPAP 35–45 mmHg) PH, and six of the 29 had post-capillary PH with PCWP &gt;15 mmHg. A total of 24 of the 29 patients were treated with PAH-targeted therapy, and they tolerated a single, dual, or triple-agent PAH regimen well. Importantly, the PAH-targeted treatment did not worsen V/Q mismatching, again supporting the notion that PAH-specific therapy can be safely used in SSc patients with non-severe ILD. Given the non-randomized nature of this evidence, however, more robust, large-scale, randomized studies are needed before firm conclusions and generalized clinical applications can be made.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d27117e603>Soluble guanylate cyclase stimulators in systemic sclerosis associated with pulmonary arterial hypertension</h2><p class="" id=d27117e606>Soluble guanylate cyclase (sGC) stimulators, another class of PAH-targeted drugs, have recently gained interest for their potential use in SSc-PAH. In addition to vasodilation, sGC stimulation and a resultant increase in the cyclic guanosine monophosphate level produce an antifibrotic effect by inhibiting non-canonical TGF-β signaling pathways<sup><a href="#ref-85">85</a></sup>. In mice, the sGC stimulator BAY 41-2272 prevented and reversed skin fibrosis<sup><a href="#ref-86">86</a></sup>. Similarly, riociguat, another sGC stimulator in clinical use, was shown to be effective against skin and gastrointestinal tract fibrosis in multiple mouse models, with its antifibrotic effect more pronounced than that of sildenafil<sup><a href="#ref-87">87</a></sup>.</p><p class="" id=d27117e621>Since SSc is characterized by fibrosis as well as vasculopathy, sGC stimulators with both antifibrotic and vasodilatory effects are considered promising candidates for the treatment of SSc-PAH. Pulmonary Arterial Hypertension Soluble Guanylate Cyclase-Stimulator Trial (PATENT)-1 was a double-blind randomized international study that established the efficacy of riociguat in PAH patients, which was extended to PATENT-2 for the assessment of long-term effects of riociguat<sup><a href="#ref-88">88</a>,<a href="#ref-89">89</a></sup>. A recent subgroup analysis of the two trials demonstrated in SSc-PAH patients that riociguat was associated with improvement in cardiac index and reduction in PVR at 12 weeks, and possibly with an increase in the 6-minute walk distance compared to placebo<sup><a href="#ref-37">37</a></sup>. Another case series described three patients whose SSc-PAH improved after phosphodiesterase-5 inhibitors were replaced with riociguat<sup><a href="#ref-90">90</a></sup>. It remains uncertain, however, whether the antifibrotic effect of riociguat confers additional clinical benefit specific to SSc-PAH.</p><p class="" id=d27117e639>Despite these seemingly favorable outcomes, the safety and tolerability of riociguat in SSc-PAH patients with concurrent ILD are unclear. In a pilot study of 22 patients with concurrent ILD (TLC &gt;30% of predicted) and treatment-naïve precapillary PH, the use of riociguat was associated with lower PVR and higher cardiac output, suggesting riociguat can safely provide similar hemodynamic benefit in patients with SSc-ILD-PH<sup><a href="#ref-91">91</a></sup>. However, in a recently published multicenter randomized trial, Riociguat for Idiopathic Interstitial Pneumonia-Associated Pulmonary Hypertension (RISE-IIP), riociguat was associated with harm and increased mortality in patients with precapillary PH and idiopathic (therefore non-CTD) ILD (mean TLC 66% of predicted)<sup><a href="#ref-92">92</a></sup>. While RISE-IIP did not involve SSc or other CTD patients, the demonstrated negative impact of riociguat in patients with significant lung disease will likely deter future attempts to prospectively investigate sGC stimulation in SSc-ILD-PH, barring new, convincing observational data favoring its use in this patient population. Lastly, given that riociguat is effective in CTEPH<sup><a href="#ref-93">93</a></sup> and SSc patients are predisposed to VTE, another interesting question regards the potential role of sGC stimulation in SSc patients affected by CTEPH.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d27117e657>Conclusion</h2><p class="" id=d27117e660>PAH-targeted therapy appears to be well tolerated and beneficial in SSc-PAH patients with its safety further questioned in the coexistence of ILD. Challenges still remain in choosing the patient population best suited for PAH-specific medications. The distinction between SSc-PAH with ILD (WHO group 1) and SSc-ILD-PH with increased PVR (WHO group 3) is arbitrary and remains undefined. Similarly, the severity of ILD beyond which PAH-targeted therapy becomes harmful is unknown, and this threshold may in part depend on the type of ILD, patient demographics, and other comorbidities. Each SSc patient with PAH or ILD-PH may develop varying degrees of other confounding complications that can independently cause PH (e.g. myocardial fibrosis or PVOD-like changes) either before or even during PAH-targeted treatment, precluding reliable patient selection and accurate response assessment. For example, it is likely prudent to avoid indiscriminate use of PAH-targeted therapy in the presence of significant left-sided heart failure in order to prevent the potential precipitation of pulmonary edema. Furthermore, how rigorously and frequently SSc patients with established PH should be screened for other associated causes of PH is unclear. High-quality, randomized trial-based data are lacking, partially owing to the rarity of the disease.</p><p class="" id=d27117e663>Novel therapeutic approaches may clarify the unresolved treatment strategies in this patient population. Inhaled PAH-targeted therapy has the theoretical advantage of improving perfusion only in the well-ventilated areas of the lungs, thereby preventing worsened V/Q mismatch that may be seen with systemic administration of the medication. Based on this hypothesis, an ongoing clinical trial (NCT02630316) looks at the role of inhaled treprostinil in ILD-PH patients, the results of which may be applicable to SSc patients with concurrent precapillary PH and ILD. Early evidence suggests the possibility of using gene expression profiling to predict clinical course and monitor response to PAH-targeted therapy in SSc patients, although more data are needed until clinical applicability can be reached<sup><a href="#ref-94">94</a>–<a href="#ref-96">96</a></sup>. While we await answers to the aforementioned questions, the decision to implement PAH-targeted therapy in SSc will have to remain individualized, incorporating both the clinician’s experience and the patient’s values.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d27117e677>Abbreviations</h2><p class="" id=d27117e680>AMBITION, Ambrisentan and Tadalafil in Patients with Pulmonary Arterial Hypertension; CPFE, combined pulmonary fibrosis and emphysema; CTD, connective tissue disease; CTD-PAH, connective tissue disease-related pulmonary arterial hypertension; CTEPH, chronic thromboembolic pulmonary hypertension; DLCO, carbon monoxide diffusing capacity; ILD, interstitial lung disease; IPAH, idiopathic pulmonary arterial hypertension; mPAP, mean pulmonary artery pressure; PAH, pulmonary arterial hypertension; PATENT, Pulmonary Arterial Hypertension Soluble Guanylate Cyclase-Stimulator Trial; PCWP, pulmonary capillary wedge pressure; PH, pulmonary hypertension; PVOD, pulmonary veno-occlusive disease; PVR, pulmonary vascular resistance; RISE-IIP, Riociguat for Idiopathic Interstitial Pneumonia-Associated Pulmonary Hypertension; RV, right ventricle; sGC, soluble guanylate cyclase; SSc, systemic sclerosis; SSc-PAH, systemic sclerosis-associated pulmonary arterial hypertension; TLC, total lung capacity; V/Q, ventilation–perfusion; VTE, venous thromboembolism; WHO, World Health Organization.<b></b></p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d27117e688 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d27721>References</h2><div class="section ref-list"><a name=d27117e688 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d27117e695 class=n-a></a>Tamby MC, Chanseaud Y, Guillevin L, <i> et al.</i>: New insights into the pathogenesis of systemic sclerosis. <i>Autoimmun Rev.</i> 2003; <b>2</b>(3): 152–7. <a target=xrefwindow id=d27117e706 href="http://www.ncbi.nlm.nih.gov/pubmed/12848956">PubMed Abstract </a> | <a target=xrefwindow id=d27117e709 href="https://doi.org/10.1016/s1568-9972(03)00004-1">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d27117e718 class=n-a></a>Varga J: Systemic sclerosis: An update. <i>Bull NYU Hosp Jt Dis.</i> 2008; <b>66</b>(3): 198–202. <a target=xrefwindow id=d27117e726 href="http://www.ncbi.nlm.nih.gov/pubmed/18937632">PubMed Abstract </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d27117e735 class=n-a></a>LeRoy EC, Medsger TA Jr: Criteria for the classification of early systemic sclerosis. <i>J Rheumatol.</i> 2001; <b>28</b>(7): 1573–6. <a target=xrefwindow id=d27117e743 href="http://www.ncbi.nlm.nih.gov/pubmed/11469464">PubMed Abstract </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d27117e752 class=n-a></a>Medsger TA Jr: Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. <i>Rheum Dis Clin North Am.</i> 2003; <b>29</b>(2): 255–73, vi. <a target=xrefwindow id=d27117e760 href="http://www.ncbi.nlm.nih.gov/pubmed/12841294">PubMed Abstract </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d27117e769 class=n-a></a>Poormoghim H, Lucas M, Fertig N, <i> et al.</i>: Systemic sclerosis sine scleroderma: Demographic, clinical, and serologic features and survival in forty-eight patients. <i>Arthritis Rheum.</i> 2000; <b>43</b>(2): 444–51. <a target=xrefwindow id=d27117e780 href="http://www.ncbi.nlm.nih.gov/pubmed/10693887">PubMed Abstract </a> | <a target="xrefwindow" id="d27117e783" href="https://doi.org/10.1002/1529-0131(200002)43:2<444::AID-ANR27&gt;3.0.CO;2-G">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d27117e793 class=n-a></a>Hachulla E, Launay D: Diagnosis and classification of systemic sclerosis. <i>Clin Rev Allergy Immunol.</i> 2011; <b>40</b>(2): 78–83. <a target=xrefwindow id=d27117e801 href="http://www.ncbi.nlm.nih.gov/pubmed/20143182">PubMed Abstract </a> | <a target=xrefwindow id=d27117e804 href="https://doi.org/10.1007/s12016-010-8198-y">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1090635"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e813 class=n-a></a>Steen VD, Medsger TA: Changes in causes of death in systemic sclerosis, 1972-2002. <i>Ann Rheum Dis.</i> 2007; <b>66</b>(7): 940–4. <a target=xrefwindow id=d27117e821 href="http://www.ncbi.nlm.nih.gov/pubmed/17329309">PubMed Abstract </a> | <a target=xrefwindow id=d27117e824 href="https://doi.org/10.1136/ard.2006.066068">Publisher Full Text </a> | <a target=xrefwindow id=d27117e827 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1955114">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1090635">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d27117e840 class=n-a></a>Tyndall AJ, Bannert B, Vonk M, <i> et al.</i>: Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. <i>Ann Rheum Dis.</i> 2010; <b>69</b>(10): 1809–15. <a target=xrefwindow id=d27117e851 href="http://www.ncbi.nlm.nih.gov/pubmed/20551155">PubMed Abstract </a> | <a target=xrefwindow id=d27117e854 href="https://doi.org/10.1136/ard.2009.114264">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d27117e863 class=n-a></a>Hachulla E, Carpentier P, Gressin V, <i> et al.</i>: Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study. <i>Rheumatology (Oxford).</i> 2009; <b>48</b>(3): 304–8. <a target=xrefwindow id=d27117e874 href="http://www.ncbi.nlm.nih.gov/pubmed/19174571">PubMed Abstract </a> | <a target=xrefwindow id=d27117e877 href="https://doi.org/10.1093/rheumatology/ken488">Publisher Full Text </a> | <a target=xrefwindow id=d27117e881 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2644045">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1156982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e890 class=n-a></a>Condliffe R, Kiely DG, Peacock AJ, <i> et al.</i>: Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era. <i>Am J Respir Crit Care Med.</i> 2009; <b>179</b>(2): 151–7. <a target=xrefwindow id=d27117e901 href="http://www.ncbi.nlm.nih.gov/pubmed/18931333">PubMed Abstract </a> | <a target=xrefwindow id=d27117e904 href="https://doi.org/10.1164/rccm.200806-953OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1156982">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717965310"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e917 class=n-a></a>Launay D, Sitbon O, Hachulla E, <i> et al.</i>: Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era. <i>Ann Rheum Dis.</i> 2013; <b>72</b>(12): 1940–6. <a target=xrefwindow id=d27117e928 href="http://www.ncbi.nlm.nih.gov/pubmed/23178295">PubMed Abstract </a> | <a target=xrefwindow id=d27117e931 href="https://doi.org/10.1136/annrheumdis-2012-202489">Publisher Full Text </a> | <a target=xrefwindow id=d27117e935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3841769">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717965310">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d27117e949 class=n-a></a>Galiè N, Humbert M, Vachiery J, <i> et al.</i>: 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J 2015; 46: 903-975. <i>Eur Respir J.</i> 2015; <b>46</b>(6): 1855–6. <a target=xrefwindow id=d27117e960 href="http://www.ncbi.nlm.nih.gov/pubmed/26621899">PubMed Abstract </a> | <a target=xrefwindow id=d27117e963 href="https://doi.org/10.1183/13993003.51032-2015">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734628296"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e972 class=n-a></a>Simonneau G, Montani D, Celermajer DS, <i> et al.</i>: Haemodynamic definitions and updated clinical classification of pulmonary hypertension. <i>Eur Respir J.</i> 2019; <b>53</b>(1): pii: 1801913. <a target=xrefwindow id=d27117e983 href="http://www.ncbi.nlm.nih.gov/pubmed/30545968">PubMed Abstract </a> | <a target=xrefwindow id=d27117e986 href="https://doi.org/10.1183/13993003.01913-2018">Publisher Full Text </a> | <a target=xrefwindow id=d27117e990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6351336">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734628296">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724376583"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1003 class=n-a></a>Avouac J, Airò P, Meune C, <i> et al.</i>: Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies. <i>J Rheumatol.</i> 2010; <b>37</b>(11): 2290–8. <a target=xrefwindow id=d27117e1014 href="http://www.ncbi.nlm.nih.gov/pubmed/20810505">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1017 href="https://doi.org/10.3899/jrheum.100245">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724376583">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8301"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1030 class=n-a></a>Hachulla E, Gressin V, Guillevin L, <i> et al.</i>: Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. <i>Arthritis Rheum.</i> 2005; <b>52</b>(12): 3792–800. <a target=xrefwindow id=d27117e1041 href="http://www.ncbi.nlm.nih.gov/pubmed/16320330">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1044 href="https://doi.org/10.1002/art.21433">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8301">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d27117e1057 class=n-a></a>Mukerjee D, St George D, Coleiro B, <i> et al.</i>: Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach. <i>Ann Rheum Dis.</i> 2003; <b>62</b>(11): 1088–93. <a target=xrefwindow id=d27117e1068 href="http://www.ncbi.nlm.nih.gov/pubmed/14583573">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1071 href="https://doi.org/10.1136/ard.62.11.1088">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1075 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1754353">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727381040"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1084 class=n-a></a>Morrisroe K, Stevens W, Sahhar J, <i> et al.</i>: Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: Results from a real-life screening programme. <i>Arthritis Res Ther.</i> 2017; <b>19</b>(1): 42. <a target=xrefwindow id=d27117e1095 href="http://www.ncbi.nlm.nih.gov/pubmed/28270192">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1098 href="https://doi.org/10.1186/s13075-017-1250-z">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1102 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5341425">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727381040">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d27117e1116 class=n-a></a>McGoon MD, Benza RL, Escribano-Subias P, <i> et al.</i>: Pulmonary arterial hypertension: epidemiology and registries. <i>J Am Coll Cardiol.</i> 2013; <b>62</b>(25 Suppl): D51–D59. <a target=xrefwindow id=d27117e1127 href="http://www.ncbi.nlm.nih.gov/pubmed/24355642">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1130 href="https://doi.org/10.1016/j.jacc.2013.10.023">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d27117e1139 class=n-a></a>Hachulla E, de Groote P, Gressin V, <i> et al.</i>: The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. <i>Arthritis Rheum.</i> 2009; <b>60</b>(6): 1831–9. <a target=xrefwindow id=d27117e1150 href="http://www.ncbi.nlm.nih.gov/pubmed/19479881">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1153 href="https://doi.org/10.1002/art.24525">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735464002"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1162 class=n-a></a>Pokeerbux MR, Giovannelli J, Dauchet L, <i> et al.</i>: Survival and prognosis factors in systemic sclerosis: Data of a French multicenter cohort, systematic review, and meta-analysis of the literature. <i>Arthritis Res Ther.</i> 2019; <b>21</b>(1): 86. <a target=xrefwindow id=d27117e1173 href="http://www.ncbi.nlm.nih.gov/pubmed/30944015">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1176 href="https://doi.org/10.1186/s13075-019-1867-1">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1180 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6446383">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735464002">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727149760"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1193 class=n-a></a>Hao Y, Hudson M, Baron M, <i> et al.</i>: Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(5): 1067–77. <a target=xrefwindow id=d27117e1204 href="http://www.ncbi.nlm.nih.gov/pubmed/28029745">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1207 href="https://doi.org/10.1002/art.40027">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727149760">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727683731"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1220 class=n-a></a>Morrisroe K, Stevens W, Huq M, <i> et al.</i>: Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. <i>Arthritis Res Ther.</i> 2017; <b>19</b>(1): 122. <a target=xrefwindow id=d27117e1231 href="http://www.ncbi.nlm.nih.gov/pubmed/28576149">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1234 href="https://doi.org/10.1186/s13075-017-1341-x">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1238 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5457656">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727683731">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d27117e1251 class=n-a></a>Hurdman J, Condliffe R, Elliot CA, <i> et al.</i>: ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. <i>Eur Respir J.</i> 2012; <b>39</b>(4): 945–55. <a target=xrefwindow id=d27117e1262 href="http://www.ncbi.nlm.nih.gov/pubmed/21885399">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1265 href="https://doi.org/10.1183/09031936.00078411">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d27117e1275 class=n-a></a>Kawut SM, Taichman DB, Archer-Chicko CL, <i> et al.</i>: Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. <i>Chest.</i> 2003; <b>123</b>(2): 344–50. <a target=xrefwindow id=d27117e1286 href="http://www.ncbi.nlm.nih.gov/pubmed/12576350">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1289 href="https://doi.org/10.1378/chest.123.2.344">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d27117e1298 class=n-a></a>Chung L, Liu J, Parsons L, <i> et al.</i>: Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: Identifying systemic sclerosis as a unique phenotype. <i>Chest.</i> 2010; <b>138</b>(6): 1383–94. <a target=xrefwindow id=d27117e1309 href="http://www.ncbi.nlm.nih.gov/pubmed/20507945">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1312 href="https://doi.org/10.1378/chest.10-0260">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1316 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3621419">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d27117e1325 class=n-a></a>Clements PJ, Tan M, McLaughlin VV, <i> et al.</i>: The pulmonary arterial hypertension quality enhancement research initiative: Comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. <i>Ann Rheum Dis.</i> 2012; <b>71</b>(2): 249–52. <a target=xrefwindow id=d27117e1336 href="http://www.ncbi.nlm.nih.gov/pubmed/21998119">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1339 href="https://doi.org/10.1136/annrheumdis-2011-200265">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d27117e1348 class=n-a></a>Fisher MR, Mathai SC, Champion HC, <i> et al.</i>: Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. <i>Arthritis Rheum.</i> 2006; <b>54</b>(9): 3043–50. <a target=xrefwindow id=d27117e1359 href="http://www.ncbi.nlm.nih.gov/pubmed/16947776">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1362 href="https://doi.org/10.1002/art.22069">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726763175"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1371 class=n-a></a>Ramjug S, Hussain N, Hurdman J, <i> et al.</i>: Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension. <i>Respirology.</i> 2017; <b>22</b>(2): 372–7. <a target=xrefwindow id=d27117e1382 href="http://www.ncbi.nlm.nih.gov/pubmed/27651181">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1385 href="https://doi.org/10.1111/resp.12899">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726763175">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718018237"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1398 class=n-a></a>Rubenfire M, Huffman MD, Krishnan S, <i> et al.</i>: Survival in Systemic Sclerosis With Pulmonary Arterial Hypertension Has Not Improved in the Modern Era. <i>Chest.</i> 2013; <b>144</b>(4): 1282–90. <a target=xrefwindow id=d27117e1409 href="http://www.ncbi.nlm.nih.gov/pubmed/23744060">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1412 href="https://doi.org/10.1378/chest.12-0653">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718018237">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727331460"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1426 class=n-a></a>Ramjug S, Hussain N, Hurdman J, <i> et al.</i>: Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes. <i>Chest.</i> 2017; <b>152</b>(1): 92–102. <a target=xrefwindow id=d27117e1437 href="http://www.ncbi.nlm.nih.gov/pubmed/28223154">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1440 href="https://doi.org/10.1016/j.chest.2017.02.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727331460">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d27117e1453 class=n-a></a>Overbeek MJ, Lankhaar JW, Westerhof N, <i> et al.</i>: Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. <i>Eur Respir J.</i> 2008; <b>31</b>(6): 1160–6. <a target=xrefwindow id=d27117e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/18216049">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1467 href="https://doi.org/10.1183/09031936.00135407">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718022833"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1476 class=n-a></a>Tedford RJ, Mudd JO, Girgis RE, <i> et al.</i>: Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. <i>Circ Heart Fail.</i> 2013; <b>6</b>(5): 953–63. <a target=xrefwindow id=d27117e1487 href="http://www.ncbi.nlm.nih.gov/pubmed/23797369">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1490 href="https://doi.org/10.1161/CIRCHEARTFAILURE.112.000008">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3815697">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718022833">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727388738"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1508 class=n-a></a>Argula RG, Karwa A, Lauer A, <i> et al.</i>: Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension. <i>Ann Am Thorac Soc .</i> 2017; <b>14</b>(5): 682–689. <a target=xrefwindow id=d27117e1519 href="http://www.ncbi.nlm.nih.gov/pubmed/28282243">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1522 href="https://doi.org/10.1513/AnnalsATS.201608-655OC">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1526 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5802595">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727388738">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d27117e1540 class=n-a></a>Chung L, Farber HW, Benza R, <i> et al.</i>: Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. <i>Chest.</i> 2014; <b>146</b>(6): 1494–504. <a target=xrefwindow id=d27117e1551 href="http://www.ncbi.nlm.nih.gov/pubmed/24992469">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1554 href="https://doi.org/10.1378/chest.13-3014">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1558 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4251613">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725744969"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1567 class=n-a></a>Galiè N, Barberà JA, Frost AE, <i> et al.</i>: Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. <i>N Engl J Med.</i> 2015; <b>373</b>(9): 834–44. <a target=xrefwindow id=d27117e1578 href="http://www.ncbi.nlm.nih.gov/pubmed/26308684">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1581 href="https://doi.org/10.1056/NEJMoa1413687">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725744969">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727160572"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1596 class=n-a></a>Coghlan JG, Galiè N, Barberà JA, <i> et al.</i>: Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(7): 1219–27. <a target=xrefwindow id=d27117e1607 href="http://www.ncbi.nlm.nih.gov/pubmed/28039187">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1610 href="https://doi.org/10.1136/annrheumdis-2016-210236">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1614 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5530350">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727160572">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726579752"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1628 class=n-a></a>Humbert M, Coghlan JG, Ghofrani HA, <i> et al.</i>: Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(2): 422–6. <a target=xrefwindow id=d27117e1639 href="http://www.ncbi.nlm.nih.gov/pubmed/27457511">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1642 href="https://doi.org/10.1136/annrheumdis-2015-209087">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1646 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5284330">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726579752">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728772371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1660 class=n-a></a>Gaine S, Chin K, Coghlan G, <i> et al.</i>: Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. <i>Eur Respir J.</i> 2017; <b>50</b>(2): pii: 1602493. <a target=xrefwindow id=d27117e1671 href="http://www.ncbi.nlm.nih.gov/pubmed/28818881">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1674 href="https://doi.org/10.1183/13993003.02493-2016">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1678 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5593379">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728772371">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d27117e1692 class=n-a></a>Lammi MR, Mathai SC, Saketkoo LA, <i> et al.</i>: Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(3): 740–8. <a target=xrefwindow id=d27117e1703 href="http://www.ncbi.nlm.nih.gov/pubmed/26479414">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1706 href="https://doi.org/10.1002/art.39478">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1710 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4996356">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d27117e1719 class=n-a></a>Hesselstrand R, Wildt M, Ekmehag B, <i> et al.</i>: Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. <i>Scand J Rheumatol.</i> 2010; <b>40</b>(2): 127–32. <a target=xrefwindow id=d27117e1730 href="http://www.ncbi.nlm.nih.gov/pubmed/20858146">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1733 href="https://doi.org/10.3109/03009742.2010.508751">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d27117e1742 class=n-a></a>Farber HW, Miller DP, Poms AD, <i> et al.</i>: Five-Year outcomes of patients enrolled in the REVEAL Registry. <i>Chest.</i> 2015; <b>148</b>(4): 1043–54. <a target=xrefwindow id=d27117e1753 href="http://www.ncbi.nlm.nih.gov/pubmed/26066077">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1756 href="https://doi.org/10.1378/chest.15-0300">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718017762"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1766 class=n-a></a>Lefèvre G, Dauchet L, Hachulla E, <i> et al.</i>: Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. <i>Arthritis Rheum.</i> 2013; <b>65</b>(9): 2412–23. <a target=xrefwindow id=d27117e1777 href="http://www.ncbi.nlm.nih.gov/pubmed/23740572">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1780 href="https://doi.org/10.1002/art.38029">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718017762">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d27117e1794 class=n-a></a>Chung L, Domsic RT, Lingala B, <i> et al.</i>: Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. <i>Arthritis Care Res (Hoboken).</i> 2014; <b>66</b>(3): 489–95. <a target=xrefwindow id=d27117e1805 href="http://www.ncbi.nlm.nih.gov/pubmed/23983198">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1808 href="https://doi.org/10.1002/acr.22121">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733261160"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1817 class=n-a></a>Kolstad KD, Li S, Steen V, <i> et al.</i>: Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS). <i>Chest.</i> 2018; <b>154</b>(4): 862–71. <a target=xrefwindow id=d27117e1828 href="http://www.ncbi.nlm.nih.gov/pubmed/29777655">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1831 href="https://doi.org/10.1016/j.chest.2018.05.002">Publisher Full Text </a> | <a target=xrefwindow id=d27117e1835 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6207791">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733261160">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735730413"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1849 class=n-a></a>Mullin CJ, Khair RM, Damico RL, <i> et al.</i>: Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. <i>Arthritis Rheumatol.</i> 2019; <b>71</b>(10): 1691–700. <a target=xrefwindow id=d27117e1860 href="http://www.ncbi.nlm.nih.gov/pubmed/31066998">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1863 href="https://doi.org/10.1002/art.40918">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735730413">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734228685"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1877 class=n-a></a>Mercurio V, Diab N, Peloquin G, <i> et al.</i>: Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model. <i>Eur Respir J.</i> 2018; <b>52</b>(4): pii: 1800497. <a target=xrefwindow id=d27117e1888 href="http://www.ncbi.nlm.nih.gov/pubmed/30262575">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1891 href="https://doi.org/10.1183/13993003.00497-2018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734228685">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d27117e1905 class=n-a></a>Weatherald J, Boucly A, Launay D, <i> et al.</i>: Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension. <i>Eur Respir J.</i> 2018; <b>52</b>(4): pii: 1800678. <a target=xrefwindow id=d27117e1916 href="http://www.ncbi.nlm.nih.gov/pubmed/30209196">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1919 href="https://doi.org/10.1183/13993003.00678-2018">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d27117e1929 class=n-a></a>Olsson KM, Hoeper MM: Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension. <i>Eur Respir J.</i> 2018; <b>52</b>(4): pii: 1801745. <a target=xrefwindow id=d27117e1937 href="http://www.ncbi.nlm.nih.gov/pubmed/30337490">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1940 href="https://doi.org/10.1183/13993003.01745-2018">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731429061"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e1949 class=n-a></a>Launay D, Sobanski V, Hachulla E, <i> et al.</i>: Pulmonary hypertension in systemic sclerosis: different phenotypes. <i>Eur Respir Rev.</i> 2017; <b>26</b>(145): pii: 170056. <a target=xrefwindow id=d27117e1960 href="http://www.ncbi.nlm.nih.gov/pubmed/28954767">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1963 href="https://doi.org/10.1183/16000617.0056-2017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731429061">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d27117e1977 class=n-a></a>Steen VD, Conte C, Owens GR, <i> et al.</i>: Severe restrictive lung disease in systemic sclerosis. <i>Arthritis Rheum.</i> 1994; <b>37</b>(9): 1283–9. <a target=xrefwindow id=d27117e1988 href="http://www.ncbi.nlm.nih.gov/pubmed/7945490">PubMed Abstract </a> | <a target=xrefwindow id=d27117e1991 href="https://doi.org/10.1002/art.1780370903">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d27117e2000 class=n-a></a>Schurawitzki H, Stiglbauer R, Graninger W, <i> et al.</i>: Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. <i>Radiology.</i> 1990; <b>176</b>(3): 755–9. <a target=xrefwindow id=d27117e2011 href="http://www.ncbi.nlm.nih.gov/pubmed/2389033">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2014 href="https://doi.org/10.1148/radiology.176.3.2389033">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d27117e2023 class=n-a></a>Launay D, Remy-Jardin M, Michon-Pasturel U, <i> et al.</i>: High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. <i>J Rheumatol.</i> 2006; <b>33</b>(9): 1789–801. <a target=xrefwindow id=d27117e2034 href="http://www.ncbi.nlm.nih.gov/pubmed/16960939">PubMed Abstract </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718298171"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2043 class=n-a></a>Nihtyanova SI, Schreiber BE, Ong VH, <i> et al.</i>: Prediction of pulmonary complications and long-term survival in systemic sclerosis. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(6): 1625–35. <a target=xrefwindow id=d27117e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/24591477">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2057 href="https://doi.org/10.1002/art.38390">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718298171">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d27117e2072 class=n-a></a>Le Pavec J, Launay D, Mathai SC, <i> et al.</i>: Scleroderma lung disease. <i>Clin Rev Allergy Immunol .</i> 2011; <b>40</b>(2): 104–16. <a target=xrefwindow id=d27117e2083 href="http://www.ncbi.nlm.nih.gov/pubmed/20063208">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2086 href="https://doi.org/10.1007/s12016-009-8194-2">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d27117e2095 class=n-a></a>Le Pavec J, Girgis RE, Lechtzin N, <i> et al.</i>: Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. <i>Arthritis Rheum.</i> 2011; <b>63</b>(8): 2456–64. <a target=xrefwindow id=d27117e2106 href="http://www.ncbi.nlm.nih.gov/pubmed/21538327">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2109 href="https://doi.org/10.1002/art.30423">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d27117e2118 class=n-a></a>Cottin V, Nunes H, Brillet PY, <i> et al.</i>: Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. <i>Eur Respir J.</i> 2005; <b>26</b>(4): 586–93. <a target=xrefwindow id=d27117e2129 href="http://www.ncbi.nlm.nih.gov/pubmed/16204587">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2132 href="https://doi.org/10.1183/09031936.05.00021005">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d27117e2141 class=n-a></a>Antoniou KM, Margaritopoulos GA, Goh NS, <i> et al.</i>: Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(4): 1004–12. <a target=xrefwindow id=d27117e2152 href="http://www.ncbi.nlm.nih.gov/pubmed/26636545">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2155 href="https://doi.org/10.1002/art.39528">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d27117e2164 class=n-a></a>Cottin V, Cordier JF: Combined pulmonary fibrosis and emphysema in connective tissue disease. <i>Curr Opin Pulm Med.</i> 2012; <b>18</b>(5): 418–27. <a target=xrefwindow id=d27117e2172 href="http://www.ncbi.nlm.nih.gov/pubmed/22781207">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2175 href="https://doi.org/10.1097/MCP.0b013e328356803b">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734446217"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2184 class=n-a></a>Champtiaux N, Cottin V, Chassagnon G, <i> et al.</i>: Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality. <i>Semin Arthritis Rheum.</i> 2019; <b>49</b>(1): 98–104. <a target=xrefwindow id=d27117e2195 href="http://www.ncbi.nlm.nih.gov/pubmed/30409416">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2198 href="https://doi.org/10.1016/j.semarthrit.2018.10.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734446217">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d27117e2213 class=n-a></a>Cottin V, Nunes H, Mouthon L, <i> et al.</i>: Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. <i>Arthritis Rheum.</i> 2011; <b>63</b>(1): 295–304. <a target=xrefwindow id=d27117e2224 href="http://www.ncbi.nlm.nih.gov/pubmed/20936629">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2227 href="https://doi.org/10.1002/art.30077">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1072025"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2236 class=n-a></a>Dorfmüller P, Humbert M, Perros F, <i> et al.</i>: Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. <i>Hum Pathol.</i> 2007; <b>38</b>(6): 893–902. <a target=xrefwindow id=d27117e2247 href="http://www.ncbi.nlm.nih.gov/pubmed/17376507">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2250 href="https://doi.org/10.1016/j.humpath.2006.11.022">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1072025">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1163330"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2263 class=n-a></a>Overbeek MJ, Vonk MC, Boonstra A, <i> et al.</i>: Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: A distinctive vasculopathy. <i>Eur Respir J.</i> 2009; <b>34</b>(2): 371–9. <a target=xrefwindow id=d27117e2274 href="http://www.ncbi.nlm.nih.gov/pubmed/19282344">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2277 href="https://doi.org/10.1183/09031936.00106008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1163330">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724434847"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2290 class=n-a></a>Günther S, Jaïs X, Maitre S, <i> et al.</i>: Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. <i>Arthritis Rheum.</i> 2012; <b>64</b>(9): 2995–3005. <a target=xrefwindow id=d27117e2301 href="http://www.ncbi.nlm.nih.gov/pubmed/22549387">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2304 href="https://doi.org/10.1002/art.34501">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724434847">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731989347"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2317 class=n-a></a>Connolly MJ, Abdullah S, Ridout DA, <i> et al.</i>: Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension. <i>Rheumatology (Oxford).</i> 2017; <b>56</b>(12): 2197–2203. <a target=xrefwindow id=d27117e2328 href="http://www.ncbi.nlm.nih.gov/pubmed/29029203">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2331 href="https://doi.org/10.1093/rheumatology/kex351">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731989347">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d27117e2344 class=n-a></a>McGuire F, Kennelly T, Tillack T, <i> et al.</i>: Pulmonary capillary hemangiomatosis associated with CREST syndrome: a case report and review of the literature. <i>Respiration.</i> 2010; <b>80</b>(5): 435–8. <a target=xrefwindow id=d27117e2355 href="http://www.ncbi.nlm.nih.gov/pubmed/20453487">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2358 href="https://doi.org/10.1159/000314587">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d27117e2368 class=n-a></a>Follansbee WP, Miller TR, Curtiss EI, <i> et al.</i>: A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). <i>J Rheumatol.</i> 1990; <b>17</b>(5): 656–62. <a target=xrefwindow id=d27117e2379 href="http://www.ncbi.nlm.nih.gov/pubmed/2359076">PubMed Abstract </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d27117e2388 class=n-a></a>Hachulla AL, Launay D, Gaxotte V, <i> et al.</i>: Cardiac magnetic resonance imaging in systemic sclerosis: A cross-sectional observational study of 52 patients. <i>Ann Rheum Dis.</i> 2009; <b>68</b>(12): 1878–84. <a target=xrefwindow id=d27117e2399 href="http://www.ncbi.nlm.nih.gov/pubmed/19054830">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2402 href="https://doi.org/10.1136/ard.2008.095836">Publisher Full Text </a> | <a target=xrefwindow id=d27117e2406 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2770106">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727704755"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2415 class=n-a></a>Bourji KI, Kelemen BW, Mathai SC, <i> et al.</i>: Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction. <i>Pulm Circ.</i> 2017; <b>7</b>(2): 409–20. <a target=xrefwindow id=d27117e2426 href="http://www.ncbi.nlm.nih.gov/pubmed/28597765">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2429 href="https://doi.org/10.1177/2045893217700438">Publisher Full Text </a> | <a target=xrefwindow id=d27117e2433 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5467929">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727704755">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d27117e2446 class=n-a></a>Chu SY, Chen YJ, Liu CJ, <i> et al.</i>: Increased risk of acute myocardial infarction in systemic sclerosis: A nationwide population-based study. <i>Am J Med.</i> 2013; <b>126</b>(11): 982–8. <a target=xrefwindow id=d27117e2457 href="http://www.ncbi.nlm.nih.gov/pubmed/24157289">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2460 href="https://doi.org/10.1016/j.amjmed.2013.06.025">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d27117e2469 class=n-a></a>Au K, Singh MK, Bodukam V, <i> et al.</i>: Atherosclerosis in systemic sclerosis: A systematic review and meta-analysis. <i>Arthritis Rheum.</i> 2011; <b>63</b>(7): 2078–90. <a target=xrefwindow id=d27117e2480 href="http://www.ncbi.nlm.nih.gov/pubmed/21480189">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2483 href="https://doi.org/10.1002/art.30380">Publisher Full Text </a> | <a target=xrefwindow id=d27117e2487 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3128188">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718128697"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2496 class=n-a></a>Fox BD, Shimony A, Langleben D, <i> et al.</i>: High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. <i>Eur Respir J.</i> 2013; <b>42</b>(4): 1083–91. <a target=xrefwindow id=d27117e2507 href="http://www.ncbi.nlm.nih.gov/pubmed/23258775">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2510 href="https://doi.org/10.1183/09031936.00091212">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718128697">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d27117e2524 class=n-a></a>Schoenfeld SR, Choi HK, Sayre EC, <i> et al.</i>: Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study. <i>Arthritis Care Res (Hoboken).</i> 2016; <b>68</b>(2): 246–53. <a target=xrefwindow id=d27117e2535 href="http://www.ncbi.nlm.nih.gov/pubmed/26212772">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2538 href="https://doi.org/10.1002/acr.22673">Publisher Full Text </a> | <a target=xrefwindow id=d27117e2542 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5399674">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d27117e2551 class=n-a></a>Ungprasert P, Srivali N, Kittanamongkolchai W: Systemic sclerosis and risk of venous thromboembolism: A systematic review and meta-analysis. <i>Mod Rheumatol.</i> 2015; <b>25</b>(6): 893–7. <a target=xrefwindow id=d27117e2559 href="http://www.ncbi.nlm.nih.gov/pubmed/25849852">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2562 href="https://doi.org/10.3109/14397595.2015.1038456">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d27117e2571 class=n-a></a>Chung WS, Lin CL, Sung FC, <i> et al.</i>: Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: A nationwide cohort study. <i>Rheumatology (Oxford).</i> 2014; <b>53</b>(9): 1639–45. <a target=xrefwindow id=d27117e2582 href="http://www.ncbi.nlm.nih.gov/pubmed/24717920">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2585 href="https://doi.org/10.1093/rheumatology/keu133">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d27117e2594 class=n-a></a>Morrisroe KB, Stevens W, Nandurkar H, <i> et al.</i>: The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis. <i>Clin Exp Rheumatol.</i> 2014; <b>32</b>(6 Suppl 86): S-133–7. <a target=xrefwindow id=d27117e2605 href="http://www.ncbi.nlm.nih.gov/pubmed/24564981">PubMed Abstract </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737062713"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2614 class=n-a></a>Merashli M, Alves J, Ames PRJ: Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis. <i>Semin Arthritis Rheum.</i> 2017; <b>46</b>(5): 615–624. <a target=xrefwindow id=d27117e2622 href="http://www.ncbi.nlm.nih.gov/pubmed/27838012">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2625 href="https://doi.org/10.1016/j.semarthrit.2016.10.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737062713">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d27117e2638 class=n-a></a>Sanna G, Bertolaccini ML, Mameli A, <i> et al.</i>: Antiphospholipid antibodies in patients with scleroderma: Prevalence and clinical significance. <i>Ann Rheum Dis.</i> 2005; <b>64</b>(12): 1795–6. <a target=xrefwindow id=d27117e2649 href="http://www.ncbi.nlm.nih.gov/pubmed/16284349">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2652 href="https://doi.org/10.1136/ard.2005.038430">Publisher Full Text </a> | <a target=xrefwindow id=d27117e2656 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1755293">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734227481"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2666 class=n-a></a>Nunes JPL, Cunha AC, Meirinhos T, <i> et al.</i>: Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma - A review. <i>Autoimmun Rev.</i> 2018; <b>17</b>(12): 1186–1201. <a target=xrefwindow id=d27117e2677 href="http://www.ncbi.nlm.nih.gov/pubmed/30316987">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2680 href="https://doi.org/10.1016/j.autrev.2018.06.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734227481">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726852586"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2693 class=n-a></a>Zheng B, Vincent C, Fritzler MJ, <i> et al.</i>: Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria. <i>J Rheumatol.</i> 2017; <b>44</b>(1): 33–9. <a target=xrefwindow id=d27117e2704 href="http://www.ncbi.nlm.nih.gov/pubmed/27744398">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2707 href="https://doi.org/10.3899/jrheum.160243">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726852586">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d27117e2720 class=n-a></a>Ohira H, Watanabe H: Pathophysiology and recent findings of primary biliary cirrhosis complicated by systemic sclerosis. <i>Hepatol Res.</i> 2014; <b>44</b>(4): 377–83. <a target=xrefwindow id=d27117e2728 href="http://www.ncbi.nlm.nih.gov/pubmed/24308674">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2731 href="https://doi.org/10.1111/hepr.12285">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727153124"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2740 class=n-a></a>Michelfelder M, Becker M, Riedlinger A, <i> et al.</i>: Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity. <i>Clin Rheumatol.</i> 2017; <b>36</b>(2): 381–390. <a target=xrefwindow id=d27117e2751 href="http://www.ncbi.nlm.nih.gov/pubmed/28028682">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2754 href="https://doi.org/10.1007/s10067-016-3504-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727153124">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d27117e2767 class=n-a></a>Volkmann ER, Saggar R, Khanna D, <i> et al.</i>: Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and Interstitial lung disease. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(7): 1900–8. <a target=xrefwindow id=d27117e2778 href="http://www.ncbi.nlm.nih.gov/pubmed/24729406">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2781 href="https://doi.org/10.1002/art.38623">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1108827"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2790 class=n-a></a>Goh NS, Desai SR, Veeraraghavan S, <i> et al.</i>: Interstitial Lung Disease in Systemic Sclerosis: a simple staging system. <i>Am J Respir Crit Care Med.</i> 2008; <b>177</b>(11): 1248–54. <a target=xrefwindow id=d27117e2801 href="http://www.ncbi.nlm.nih.gov/pubmed/18369202">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2804 href="https://doi.org/10.1164/rccm.200706-877OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1108827">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735094847"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2818 class=n-a></a>Young A, Vummidi D, Visovatti S, <i> et al.</i>: Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis. <i>Arthritis Rheumatology.</i> 2019; <b>71</b>(8): 1339–49. <a target=xrefwindow id=d27117e2829 href="http://www.ncbi.nlm.nih.gov/pubmed/30762947">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2832 href="https://doi.org/10.1002/art.40862">Publisher Full Text </a> | <a target=xrefwindow id=d27117e2836 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6663644">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735094847">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d27117e2849 class=n-a></a>Beyer C, Zenzmaier C, Palumbo-Zerr K, <i> et al.</i>: Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(7): 1408–16. <a target=xrefwindow id=d27117e2860 href="http://www.ncbi.nlm.nih.gov/pubmed/24567525">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2863 href="https://doi.org/10.1136/annrheumdis-2013-204508">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d27117e2872 class=n-a></a>Beyer C, Reich N, Schindler SC, <i> et al.</i>: Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis. <i>Ann Rheum Dis.</i> 2012; <b>71</b>(6): 1019–26. <a target=xrefwindow id=d27117e2883 href="http://www.ncbi.nlm.nih.gov/pubmed/22294631">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2886 href="https://doi.org/10.1136/annrheumdis-2011-200862">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d27117e2895 class=n-a></a>Dees C, Beyer C, Distler A, <i> et al.</i>: Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(8): 1621–5. <a target=xrefwindow id=d27117e2906 href="http://www.ncbi.nlm.nih.gov/pubmed/25817717">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2909 href="https://doi.org/10.1136/annrheumdis-2014-206809">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718047146"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2918 class=n-a></a>Ghofrani HA, Galiè N, Grimminger F, <i> et al.</i>: Riociguat for the treatment of pulmonary arterial hypertension. <i>N Engl J Med.</i> 2013; <b>369</b>(4): 330–40. <a target=xrefwindow id=d27117e2929 href="http://www.ncbi.nlm.nih.gov/pubmed/23883378">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2932 href="https://doi.org/10.1056/NEJMoa1209655">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718047146">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725324589"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2945 class=n-a></a>Rubin LJ, Galie N, Grimminger F, <i> et al.</i>: Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2). <i>Eur Respir J.</i> 2015; <b>45</b>(5): 1303–1313. <a target=xrefwindow id=d27117e2956 href="http://www.ncbi.nlm.nih.gov/pubmed/25614164">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2959 href="https://doi.org/10.1183/09031936.00090614">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725324589">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737062714"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e2973 class=n-a></a>Raina A, Benza RL, Farber HW: Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: A case series. <i>Pulm Circ.</i> 2017; <b>7</b>(3): 741–6. <a target=xrefwindow id=d27117e2981 href="http://www.ncbi.nlm.nih.gov/pubmed/28671485">PubMed Abstract </a> | <a target=xrefwindow id=d27117e2984 href="https://doi.org/10.1177/2045893217721694">Publisher Full Text </a> | <a target=xrefwindow id=d27117e2987 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5841890">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737062714">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d27117e3000 class=n-a></a>Hoeper MM, Halank M, Wilkens H, <i> et al.</i>: Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial. <i>Eur Respir J.</i> 2013; <b>41</b>(4): 853–60. <a target=xrefwindow id=d27117e3011 href="http://www.ncbi.nlm.nih.gov/pubmed/22936711">PubMed Abstract </a> | <a target=xrefwindow id=d27117e3014 href="https://doi.org/10.1183/09031936.00213911">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736436908"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e3023 class=n-a></a>Nathan SD, Behr J, Collard HR, <i> et al.</i>: Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. <i>Lancet Respir Med.</i> 2019; <b>7</b>(9): 780–790. <a target=xrefwindow id=d27117e3034 href="http://www.ncbi.nlm.nih.gov/pubmed/31416769">PubMed Abstract </a> | <a target=xrefwindow id=d27117e3037 href="https://doi.org/10.1016/S2213-2600(19)30250-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736436908">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718047147"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e3050 class=n-a></a>Ghofrani HA, D'Armini AM, Grimminger F, <i> et al.</i>: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. <i>N Engl J Med.</i> 2013; <b>369</b>(4): 319–29. <a target=xrefwindow id=d27117e3061 href="http://www.ncbi.nlm.nih.gov/pubmed/23883377">PubMed Abstract </a> | <a target=xrefwindow id=d27117e3064 href="https://doi.org/10.1056/NEJMoa1209657">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718047147">F1000 Recommendation</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726628266"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e3077 class=n-a></a>Cheong FY, Gower AC, Farber HW: Changes in gene expression profiles in patients with pulmonary arterial hypertension associated with scleroderma treated with tadalafil. <i>Semin Arthritis Rheum.</i> 2017; <b>46</b>(4): 465–472. <a target=xrefwindow id=d27117e3085 href="http://www.ncbi.nlm.nih.gov/pubmed/27499522">PubMed Abstract </a> | <a target=xrefwindow id=d27117e3088 href="https://doi.org/10.1016/j.semarthrit.2016.05.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726628266">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733493332"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e3101 class=n-a></a>Moll M, Christmann RB, Zhang Y, <i> et al.</i>: Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung disease. <i>J Scleroderma Relat Disord.</i> 2018; <b>3</b>(3): 242–248. <a target=xrefwindow id=d27117e3112 href="http://www.ncbi.nlm.nih.gov/pubmed/30498788">PubMed Abstract </a> | <a target=xrefwindow id=d27117e3115 href="https://doi.org/10.1177/2397198318764780">Publisher Full Text </a> | <a target=xrefwindow id=d27117e3119 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6258027">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733493332">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727766444"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d27117e3133 class=n-a></a>Bossini-Castillo L, Campillo-Davó D, López-Isac E, <i> et al.</i>: An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis. <i>J Rheumatol.</i> 2017; <b>44</b>(10): 1453–1457. <a target=xrefwindow id=d27117e3144 href="http://www.ncbi.nlm.nih.gov/pubmed/28668810">PubMed Abstract </a> | <a target=xrefwindow id=d27117e3147 href="https://doi.org/10.3899/jrheum.161369">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727766444">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 19 Dec 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-2124.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-2124.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Colorado, USA<br/> <p> <div class=margin-bottom> Michael H Lee <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Todd M Bull <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-2124/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 19 Dec 2019, 8:2124 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.20313.1">https://doi.org/10.12688/f1000research.20313.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Lee MH and Bull TM. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=22318 data-id=20313 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20313.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-2124/v1/pdf?article_uuid=dcfcf812-2363-4880-b2b8-f96a9d0090f3" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.20313.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Lee MH and Bull TM. The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):2124 (<a href="https://doi.org/10.12688/f1000research.20313.1" target=_blank>https://doi.org/10.12688/f1000research.20313.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=20313 id=mobile-track-article-signin-20313 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20313?target=/articles/8-2124.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22318 /> <input name=articleId type=hidden value=20313 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Lewis J Rubin</strong>, Division of Pulmonary and Critical Care Medicine, University of California, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>J Gerry Coghlan</strong>, National Pulmonary Hypertension Service, Royal Free London NHS Foundation Trust, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 19 Dec 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-2124.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-2124.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=61408-57680></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=61403-57679></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-2124/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>19 Dec 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Lewis J Rubin</strong>, Division of Pulmonary and Critical Care Medicine, University of California, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>J Gerry Coghlan</strong>, National Pulmonary Hypertension Service, Royal Free London NHS Foundation Trust, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-2124.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-2124/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The role of pulmonary arterial hypertension-targeted...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-2124/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-2124/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-2124/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Lee MH and Bull TM');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-2124/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-2124",
            templates : {
                twitter : "The role of pulmonary arterial hypertension-targeted therapy.... Lee MH and Bull TM, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-2124/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/20313/22318")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "22318");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "57680": 0,
                           "57679": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "93d4720b-7181-4596-9aaa-2c1c8163cb11";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-2124.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-2124.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-2124.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-2124.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-2124.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>